Charles E. Massie
Robinson Way
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.
Journal: European urology
Published: August 06, 2023
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework.
Journal: Science advances
Published: September 28, 2022
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Journal: Science translational medicine
Published: October 10, 2019
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Journal: Genome medicine
Published: September 19, 2019
Enhanced detection of circulating tumor DNA by fragment size analysis.
Journal: Science translational medicine
Published: March 29, 2018
Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models.
Journal: Cancer research
Published: February 05, 2018
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.
Journal: Nature communications
Published: May 24, 2017
Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Journal: Nature reviews. Cancer
Published: February 25, 2017
Implementing liquid biopsies into clinical decision making for cancer immunotherapy.
Journal: Oncotarget
Published: February 08, 2017
CVE: an R package for interactive variant prioritisation in precision oncology.
Journal: BMC medical genomics
Published: September 26, 2016
Last Updated: 09/26/2026